PEDF cancer phase I Pages on BioPortfolio:

BioPortfolio - GenVec
TNFerade™ represents a novel approach to treating cancer in combination ... We have completed a Phase I clinical trial of PEDF in patients with severe AMD. ...
http://www.bioportfolio.com/biocorporate/534-GenVec.html...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
Interleukin-12 gene therapy fights liver cancer in immunosuppressed mice - ... data from phase 1 for nonHodgkin's B-cell lymphomas - Cancer Research ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - genvec ovarian cancer
tumors incl. ovarian cancer. Ib. Initiated phase Ib clinical trials in . ... Results from GenVec's Phase 1 dose-escalation safety study of PEDF in patients
...
http://www.bioportfolio.com/search/genvec_ovarian_cancer.htm...

Search BioPortfolio: BioPortfolio Web Home Careers Conferences ...
Pharma company releases data from phase 1 for nonHodgkin's B-cell lymphomas - Cancer Research ... Pigment epithelium-derived factor (PEDF) is a 50-kD. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

La Merie R&D Pipeline News Therapeutic Edition Sample
Early stage Her2+ breast cancer. Mar-ket. III. Interim results of phase .... PEDF: turn on. Plasmid DNA encoding DNA-binding protein transcription factors
...
http://www.bioportfolio.com/promote/Therapeutic%20Edition%20...

Search BioPortfolio: BioPortfolio Web Home Careers Conferences ...
Positive preliminary data reported from phase II study for squalamine - Macular ... Pigment epithelium-derived factor (PEDF) and vascular endothelial. ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

La Merie R&D Update: July 18, 2005
tumors incl. ovarian cancer. Ib. Initiated phase Ib clinical trials in .... PEDF : turn on. Plasmid DNA. encoding. DNA-binding. protein. transcription ...
http://www.bioportfolio.com/pdf/R&D_Pipeline_News_Technology...

Results from other life science and pharmaceutical sites:

PEDF: bridging neurovascular interactions in the stem cell niche ...
Kevin Pumiglia is at the Center for Cell Biology and Cancer and Sally Temple is at the .... PEDF was beneficial in Phase I clinical trials for macular ...
http://www.nature.com/neuro/journal/v9/n3/full/nn0306-299.ht...

Expression of pigment epithelial derived factor is...[Int J Mol ...
PEDF mRNA level in cancer tissue was negatively associated with TNM stage and the tumor size (p<0.05, independent t-test). Finally, low levels of PEDF in ...
http://view.ncbi.nlm.nih.gov/pubmed/16596284...

Journal of Investigative Dermatology - Loss of EPC-1//PEDF ...
As a means of examining the functional role of EPC-1/PEDF,Dawson et al (1999) ...... An open-label, phase I, single administration, dose-escalation study of
...
http://www.nature.com/jid/journal/v122/n5/full/5602311a.html...

TTUHSC :: School of Medicine
Two functional epitopes of PEDF block angiogenesis and induce differentiation in prostate cancer, Cancer Research, 65(12):5144-52. Fontana A*, Filleur S*, ...
http://www.ttuhsc.edu/som/microbiology/faculty/facultyDetail...

Expression of pigment epithelium-derived factor de...[Cancer Res ...
Department of Surgical Oncology, Division of Cancer Medicine, ... Pigment epithelium-derived factor (PEDF) is expressed in several normal organs and ...
http://www.ncbi.nlm.nih.gov/pubmed/15150108...

PEDF: a multifaceted neurotrophic factor : Article : Nature ...
PEDF is specifically induced in proliferating cells entering a G0 phase. ..... Cancer Gene Therapy Original Article (01 May 2004) ...
http://www.nature.com/nrn/journal/v4/n8/full/nrn1176.html...

[Expression of placental growth factor and pigment...[Zhonghua Yi ...
OBJECTIVE: To study the expression of placental growth factor (PlGF) and pigment epithelium-derived factor (PEDF) in non-small cell lung cancer, ...
http://www.ncbi.nlm.nih.gov/pubmed/16409837...

BioPortfolio - GenVec
TNFerade™ represents a novel approach to treating cancer in combination ... We have completed a Phase I clinical trial of PEDF in patients with severe AMD. ...
http://www.bioportfolio.com/biocorporate/534-GenVec.html...

PEDF: Raising both hopes and questions in controlling angiogenesis
This factor, PEDF, has now been purified (4) and cloned from both human (5) .... contributing to the well-known age-related increase in cancer prevalence? ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=33...

Molecular Therapy - Abstract of article: 1064. AdPEDF Therapy for ...
PEDF opposes not only VEGF but also other angiogenic stimuli such as FGF, ... PhD Studentships Division of Cancer Sciences and Molecular Pathology ...
http://www.nature.com/mt/journal/v9/n1s/abs/mt20041188a.html...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.